Related topics: Industry Drivers
The spread of swine flu has caused significant rises in the share prices of some vaccine makers, including Novavax, which rose 80 per cent, and BioCryst, which spiked by 76 per cent.
Both companies have flu vaccines in development and this has led to increased interest from investors. Novavax experienced a similar thing during a previous bird-flu scare, which took its share price over $10 but this fell considerably once the immediate concern had passed.
Other companies in the sector, such as Sanofi-Aventis, Baxter and Vical, have seen their share prices rise and Roche and GlaxoSmithKline are also likely benefit.
Copyright - Unless otherwise stated all contents of this web site are © 2000/2009 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
© 2000/2009 - Decision News Media SAS - All right reserved.
